Benej, M.; Klikovits, T.; Krajc, T.; Bohanes, T.; Schulte, L.; Hochmair, M.J.; Watzka, S.; Mosleh, B.; Hoetzenecker, K.; Aigner, C.;
et al. Lymph Node Log-Odds Ratio Accurately Defines Prognosis in Resectable Non-Small Cell Lung Cancer. Cancers 2023, 15, 2082.
https://doi.org/10.3390/cancers15072082
AMA Style
Benej M, Klikovits T, Krajc T, Bohanes T, Schulte L, Hochmair MJ, Watzka S, Mosleh B, Hoetzenecker K, Aigner C,
et al. Lymph Node Log-Odds Ratio Accurately Defines Prognosis in Resectable Non-Small Cell Lung Cancer. Cancers. 2023; 15(7):2082.
https://doi.org/10.3390/cancers15072082
Chicago/Turabian Style
Benej, Michal, Thomas Klikovits, Tibor Krajc, Tomas Bohanes, Lisa Schulte, Maximilian Johannes Hochmair, Stefan Watzka, Berta Mosleh, Konrad Hoetzenecker, Clemens Aigner,
and et al. 2023. "Lymph Node Log-Odds Ratio Accurately Defines Prognosis in Resectable Non-Small Cell Lung Cancer" Cancers 15, no. 7: 2082.
https://doi.org/10.3390/cancers15072082
APA Style
Benej, M., Klikovits, T., Krajc, T., Bohanes, T., Schulte, L., Hochmair, M. J., Watzka, S., Mosleh, B., Hoetzenecker, K., Aigner, C., Hoda, M. A., & Mueller, M. R.
(2023). Lymph Node Log-Odds Ratio Accurately Defines Prognosis in Resectable Non-Small Cell Lung Cancer. Cancers, 15(7), 2082.
https://doi.org/10.3390/cancers15072082
